304
Views
36
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Review

Cognitive and neurobehavioral features in multiple sclerosis

&
Pages 411-424 | Published online: 09 Jan 2014

References

  • Smith C, Samkoff, LM, Scheinberg, LC. Clinical features, assessment, and differential diagnosis of multiple sclerosis. In: Multiple Sclerosis: A Neuropsychiatric Disorder. Halbreich U (Ed.). American Psychiatric Press, DC, USA (1993).
  • Shnek Z, Foley FW, LaRocca NG, Smith CR, Halper J. Psychological predictors of depression in multiple sclerosis. J. Neurol. Rehab.9, 15–23 (1995).
  • Koch-Henriksen N, Sørensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol.9, 520–532 (2010).
  • Rao SM. Neuropsychology of multiple sclerosis: a critical review. J. Clin. Exp. Neuropsychol.8, 503–542 (1986).
  • Benedict RH, Cookfair D, Gavett R et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J. Int. Neuropsychol. Soc.12, 549–558 (2006).
  • Arnett PA, Smith MM. Cognitive functioning and everyday tasks in multiple sclerosis. In: The Neuropsychology of Everyday Functioning. Grant I, Marcotte T (Eds). Guilford Press, NY, USA, 357–388 (2010).
  • Benedict RH, Wahlig E, Bakshi R et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J. Neurol. Sci.231, 29–34 (2005).
  • Arnett PA, Barwick FH, Beeney JE. Depression in multiple sclerosis: review and theoretical proposal. J. Int. Neuropsychol. Soc.14, 691–724 (2008).
  • Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am. J. Psychiatry159, 1862–1868 (2002).
  • McGuigan C, Hutchinson M. Unrecognized symptoms of depression in a community-based population with multiple sclerosis. J. Neurol.253, 219–223 (2005).
  • Smith MM, Arnett PA. Factors related to employment status changes in individuals with multiple sclerosis. Mult. Scler.11, 602–609 (2005).
  • Jonsson A, Andresen J, Storr L, Tscherning T, Sorensen PS, Ravnborg M. Cognitive impairment in newly diagnosed multiple sclerosis patients: a 4-year follow-up study. J. Neurol. Sci.245, 77–85 (2006).
  • Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J. Neurol. Sci.245, 41–46 (2006).
  • Longley WA. Multiple sclerosis-related dementia: relatively rare and often misunderstood. Clin. Pract. Curr. Opin.8, 154–167 (2007).
  • Higginson CI, Arnett PA, Voss WD. The ecological validity of clinical tests of memory and attention in multiple sclerosis. Arch. Clin. Neuropsychol.15, 185–204 (2000).
  • Schultheis MT, Garay E, DeLuca J. The influence of cognitive impairment on driving performance in multiple sclerosis. Neurology56, 1089–1084 (2001).
  • Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology41(5), 692–696 (1991).
  • Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. 1. Frequency, patterns, and prediction. Neurology41, 685–691 (1991).
  • Bobholz J, Rao S. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr. Opin. Neurol.16, 283–288 (2003).
  • Winkelmann A, Engel C, Apel A, Zettl UK. Cognitive impairment in multiple sclerosis. J. Neurol.254(Suppl. 2), II35–II42 (2007).
  • Brassington JC, Marsh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol. Rev.8, 43–77 (1998).
  • Zakzanis K. Distinct neurocognitive profiles in multiple sclerosis subtypes. Arch. Clin. Neuropsychol.15, 115–136 (2000).
  • DeLuca J, Barbieri-Berger S, Johnson SK. The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. J. Clin. Exp. Neuropsychol.16(2), 183–189 (1994).
  • Lengenfelder J, Bryant D, Diamonf BJ, Kalmar JH, Moore NB, DeLuca J. Processing speed interacts with working memory efficiency in multiple sclerosis. Arch. Clin. Neuropsychol.21, 229–238 (2006).
  • Tinnefeld M, Treitz FH, Haase CG, Wilhelm H, Daum I, Faustmann PM. Attention and memory dysfunctions in mild multiple sclerosis. Eur. Arch. Psychiatry Clin. Neurosci.255, 319–326 (2005).
  • Bruce JM, Bruce AS, Arnett PA. Mild visual acuity disturbances are associated with performance on tests of complex visual attention in MS. J. Int. Neuropsychol. Soc.13, 544–548 (2007).
  • Parmenter BA, Zivadinov R, Kerenyi L et al. Validity of the Wisconsin Card Sorting and Delis-Kaplan Executive Function System (DKEFS) sorting tests in multiple sclerosis. J. Clin. Exp. Neuropsychol.29, 215–223 (2007).
  • DeSousa EG, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am. J. Alzheimer’s Dis.17, 23–29 (2002).
  • Smith MM, Arnett PA. Dysarthria predicts poorer performance on cognitive tasks requiring a speeded oral response in an MS population. J. Clin. Exp. Neuropsychol.29, 804–812 (2007).
  • Arnett PA, Smith MM, Barwick FH, Benedict RH, Ahlstrom B. Oralmotor slowing in multiple sclerosis: relationship to complex neuropsychological tasks requiring an oral response. J. Int. Neuropsychol. Soc.14, 454–462 (2008).
  • Arnett PA, Hussain M, Rao S, Swanson S, Hammeke T. Conduction aphasia in multiple sclerosis: a case report with MRI findings. Neurology47, 576–578 (1996).
  • Mackenzie C, Green J. Cognitive–linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis. Int. J. Lang. Commun. Disord.44, 401–420 (2009).
  • García MC, Plasencia PM, Benito YA, Gómez JJB, Marcos AR. Executive function and memory in patients with relapsing–remitting multiple sclerosis. Psicothema21, 416–420 (2009).
  • Denney DR, Lynch SG, Parmenter BA, Horne N. Cognitive impairment in relapsing and primary progressive multiple sclerosis: mostly a matter of speed. J. Int. Neuropsychol. Soc.10, 948–956 (2004).
  • Rao SM; Cognitive Function Study Group of the National Multiple Sclerosis Society. Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis. National Multiple Sclerosis Society, NY, USA (1990).
  • Benedict RH, Fischer JS, Archibald CJ et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin. Neuropsychol.16, 381–397 (2002).
  • Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict R. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Mult. Scler.15, 1077–1084 (2009).
  • Arnett PA, Rabinowitz AR. The neuropsychological presentation and treatment of demyelinating disorders. In: Handbook of Clinical Neuropsychology 2nd Edition. Gurd J, Marshall JC (Eds). Oxford University Press, NY, USA (2010).
  • Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology39, 161–166 (1989).
  • Brass SD, Benedict RH, Weinstock-Guttman B, Munschauer F, Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult. Scler.12, 437–444 (2006).
  • Benedict RH, Bruce JM, Dwyer MG et al. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch. Neurol.63, 1301–1306 (2006).
  • Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology44, 420–425 (1994).
  • Hillary FG, Chiaravalloti ND, Ricker JH et al. An investigation of working memory rehearsal in multiple sclerosis using fMRI. J. Clin. Exp. Neuropsychol.25, 965–978 (2003).
  • Smith AM, Walker LA, Freedman MS, DeMeulemeester C, Hogan MJ, Cameron I. fMRI investigation of disinhibition in cognitively impaired patients with multiple sclerosis. J. Neurol. Sci.28, 58–63 (2009).
  • Bonzano L, Pardini M, Mancardi GL, Pizzorno M, Roccatagliata L. Structural connectivity influences brain activation during PVSAT in multiple sclerosis. NeuroImage45, 9–15 (2009).
  • Ali E, Buckle G. Neuroimaging in multiple sclerosis. Neurol. Clin.27, 203–219 (2008).
  • Sumowski JS, Chiaravalloti N, Wylie GR, DeLuca J. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis. J. Int. Neuropsychol. Soc.15, 606–612 (2009).
  • Sumowski JF, Wylie GR, Chiaravalloti N, DeLuca J. Intellectual enrichment lessens the effect of brain atrophy on learning and memory in MS. Neurology74(24), 1942–1945 (2010).
  • Arnett PA. Does cognitive reserve apply to multiple sclerosis? Neurology74(24), 1934–1935 (2010).
  • Audoin B, Ibarrola D, Ranjeva J et al. Compensatory cortical activation observed by fMRI during a cognitive task at the earliest stage of MS. Hum. Brain Mapp.20, 51–58 (2003).
  • Arnett PA, Higginson CI, Voss WD, Randolph JJ. Relationship between coping, depression, and cognitive dysfunction in multiple sclerosis. Clin. Neuropsychol.16, 341–355 (2002).
  • Rabinowitz AR, Arnett PA. A longitudinal analysis of cognitive dysfunction, coping, and depression in multiple sclerosis. Neuropsychology23, 581–591 (2009).
  • Julian LJ, Arnett PA. Relationships among anxiety, depression symptoms, cognitive functioning, and coping in multiple sclerosis. Clin. Neuropsychol.5, 794–804 (2009).
  • Bruce JM, Bruce AS, Arnett PA. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis. Neuropsychology24, 77–83 (2010).
  • Andreasen AK, Spliid PE, Andersen H, Jakobsen J. Fatigue and processing speed are related in multiple sclerosis. Eur. J. Neurol.17, 212–218 (2010).
  • Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology55, 934–939 (2000).
  • Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology33, 1444–1452 (1983).
  • Fischer JS, Rudick RA, Cutter GA, Reingold SC. The Multiple Sclerosis Functional Composite (MSFC): an integrated approach to MS clinical outcome assessment. Mult. Scler.3, 244–250 (1999).
  • Kujala P, Portin R, Ruutiainen J. The progress of cognitive decline in multiple sclerosis: a controlled 3-year follow-up. Brain120, 289–297 (1997).
  • Deloire M, Ruet A, Hamel D, Bonnet M, Brochet B. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later. Mult. Scler.16, 581–587 (2010).
  • Christodoulou C, Melville P, Scherl WF et al. Negative affect predicts subsequent cognitive change in multiple sclerosis. J. Int. Neuropsychol. Soc.15, 53–61 (2009).
  • Amato MP, Ponziani G, Siracusa G, Sorbi S. Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years. Arch. Neurol.58, 1602–1606 (2001).
  • Achiron A, Polliack M, Rao SM et al. Cognitive patterns and progression in multiple sclerosis: construction and validation of percentile curves. J. Neurol. Neurosurg. Psychiatry76, 744–749 (2005).
  • Piras MR, Magnano I, Canu ED et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J. Neurol. Neurosurg. Psychiatry74, 878–885 (2003).
  • Chelune GJ, Feisthamel K, Stone L. Assessing the prevalence and relative risk of cognitive dysfunction in patients with multiple sclerosis. Brain Impair.5(Suppl.), 77 (2004).
  • MacAllister WS, Krupp LS. Multiple sclerosis-related fatigue. Phys. Med. Rehabil. Clin. N. Am.16, 483–502 (2005).
  • Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs17, 225–234 (2003).
  • Colosimo C, Millefiorini E, Grasso MG et al. Fatigue in MS is associated with specific clinical features. Acta Neurol. Scand.92, 353–355 (1995).
  • Kaynak H, Altintas, A, Kaynak D et al. Fatigue and sleep disturbance in multiple sclerosis. Eur. J. Neurol.13, 1333–1339 (2006).
  • Kos D, Kerckhofs E, Nagels G, D’hooghe MB, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil. Neural Repair22(1), 91–100 (2008).
  • Fisk J, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can. J. Neurol. Sci.21, 9–14 (1994).
  • Krupp L, Alvarez L, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch. Neurol.45, 435–437 (1988).
  • Julian L, Vella L, Vollmer T, Hadjimichael O, Mohr D. Employment in multiple sclerosis: exiting and re-entering the work force. J. Neurol.255, 1354–1360 (2008).
  • Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci.205(1), 51–58 (2002).
  • Vercoulen J, Hommes OR, Swanick CMA et al. The measurement of fatigue in patients with multiple sclerosis. Arch. Neurol.53, 642–648 (1996).
  • Flensner G, Ek A, Soderhamm O. Lived experience of MS-related fatigue – a phenomenological interview study. Int. J. Nurs. Stud.40, 707–717 (2003).
  • Mills R, Young CA. A medical definition of fatigue in multiple sclerosis. QJM101, 49–60 (2008).
  • Leocani L, Colombo B, Comi G. Physiopathology of fatigue in multiple sclerosis. Neurol. Sci.29(Suppl. 2), S241–S243 (2008).
  • Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Paralyzed Veterans of America, DC, USA (1998).
  • Marrie R, Fisher E, Miller DM, Lee JC, Rudick RA. Association of fatigue and brain atrophy in multiple sclerosis. J. Neurol. Sci.228(2), 161–166 (2005).
  • Tedeschi G, Dinacci D, Lavorgna L et al. Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. J. Neurol. Sci.263(1–2), 15–9 (2007).
  • Bakshi R, Miletich RS, Henschel K et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology53(5), 1151–1153 (1999).
  • Heesen C, Nawrath L, Reich C, Bauer N, Schulz KH, Gold SM. Fatigue in multiple sclerosis: an example of a mediated sickness behaviour? J. Neurol. Neurosurg. Psychiatry77(1), 34–39 (2006).
  • Chwastiak L, Gibbons LE, Ehde DM et al. Fatigue and psychiatric illness in a large sample of persons with multiple sclerosis. J. Psychosom. Res.59(5), 291–298 (2005).
  • Stanton B, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult. Scler.12, 481–486 (2006).
  • Strober LB, Arnett PA. An examination of four models predicting fatigue in multiple sclerosis. Arch. Clin. Neuropsychol.20, 631–646 (2005).
  • Patrick E, Christodoulou C, Krupp LB; New York State MS Consortium. Longitudinal correlates of fatigue in multiple sclerosis. Mult. Scler.15(2), 258–261 (2009).
  • Bamer A, Johnson KL, Amtmann D, Kraft GH. Prevalence of sleep problems in individuals with multiple sclerosis. Mult. Scler.14, 1127–1130 (2008).
  • Merlino G, Fratticci L, Lenchig C et al. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med.10, 26–34 (2009).
  • Moriera N, Damasceno RS, Medeiros CA et al. Restless leg syndrome, sleep quality, and fatigue in multiple sclerosis patients. Braz. J. Med. Biol. Res.41, 932–937 (2008).
  • Ferini-Strambi L, Filippi M, Martinelli V et al. Nocturnal sleep study in multiple sclerosis: correlates with clinical and brain magnetic resonance imaging findings. J. Neurol. Sci.125, 194–197 (1994).
  • Fleming W, Pollak CP. Sleep disorders in multiple sclerosis. Semin. Neurol.25, 64–68 (2005).
  • Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch. Neurol.49, 641–643 (1992).
  • Strober L, Arnett P, Polen D, Bruce J. Is sleep disturbance reflective of depression or disease symptomatology in multiple sclerosis. J. Neuropsychol. Soc.8(2), 258 (2002).
  • Saunders J, Whitman R, Schaumann B. Sleep disturbance, fatigue and depression in multiple sclerosis. Neurology41(Suppl. 1), 320 (1991).
  • Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur. Neurol.34, 320–323 (1994).
  • Cetin K, Johnson KL, Ehde DM, Kuehn CM, Amtmann D, Kraft GH. Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample. Mult. Scler.13, 1046–1053 (2007).
  • Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry76, 469–475 (2006).
  • Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr. Clin. North Am.30, 803–817 (2007).
  • Brønnum-Hansen H, Stenager E, Stenager EN, Koch-Henriksen N. Suicide among Danes with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry76, 1457–1459 (2005).
  • Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson’s disease: report of an NINDS/NIMH Work Group. Mov. Disord.21, 148–158 (2006).
  • Beeney JE, Arnett PE. Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms. J. Int. Neuropsychol. Soc.14, 1057–1062 (2008).
  • Moran PJ, Mohr DC. The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J. Behav. Med.28, 35–41 (2005).
  • Bruce JM, Arnett PA. Depressed MS patients exhibit affective memory biases during and after a list learning task that suppresses higher-order encoding strategies. J. Int. Neuropsychol. Soc.11, 514–521 (2005).
  • Bruce JM, Polen DM, Arnett PA. Pain and affective memory biases interact to predict depressive symptoms in multiple sclerosis. Mult. Scler.13, 58–66 (2007).
  • Beeney JE, Arnett PA. Stress and affective memory bias interact to predict depressive symptoms in multiple sclerosis. Neuropsychology22, 118–126 (2008).
  • Feinstein A. The neuropsychiatry of multiple sclerosis. Can. J. Psychiatry49, 157–163 (2004).
  • Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann K, Rudick RA. Treatment of depression improves adherence to interferon β-1b therapy for multiple sclerosis. Arch. Neurol.54, 531–533 (1997).
  • Bruce JM, Hancock LM, Arnett PA, Lynch S. Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition. J. Behav. Med.33, 219–227 (2010).
  • Mohr DC, Likosky W, Bertagnolli A et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J. Consult. Clin. Psychology68(2), 356–361 (2000).
  • Fischer JS, Foley FW, Aikens JE, Ericson DG, Rao SM, Shindell S. What do we really know about cognitive dysfunction, affective disorders, and stress in multiple sclerosis? A practitioner’s guide. J. Neurol. Rehabil.8(3), 151–164 (1994).
  • Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult. Scler.11, 328–337 (2005).
  • Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive–behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J. Consult. Clin. Psychology69(6), 1–8 (2001).
  • Ehde DM, Kraft GH, Chwastiak L et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen. Hosp. Psychiatry30, 40–48 (2008).
  • Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult. Scler.13, 67–72 (2007).
  • Gay MC, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol. Scand.121, 161–170 (2010).
  • Brown RF, Valpiani EM, Tennant CC et al. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol. Psychother.82, 41–56 (2009).
  • Mohr DC. The Stress and Mood Management Program for Individuals with Multiple Sclerosis: Therapist Guide. Oxford University Press, NY, USA (2010).
  • Thibault M, Schmidt N, Joyeux O, Bungener C, Souvignet V. Coping strategy and anxiety evolution in multiple sclerosis patients initiating interferon-β treatment. Eur. Neurol.62, 79–85 (2009).
  • Bruce JM, Arnett P. Clinical correlates of generalized worry in multiple sclerosis. J. Clin. Exp. Neuropsychol.31, 698–705 (2009).
  • Ybarra MI, Moreira MA, Araújo CR, Lana-Peixoto MA, Teixeira AL. Bipolar disorder and multiple sclerosis. Arq. Neuropsiquiatr.65, 1177–1180 (2007).
  • Haiman G, Pratt H, Miller A. Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect. J. Clin. Psychopharmacol.29, 444–452 (2009).
  • Nyenhuis DL, Rao SM, Zajecka J, Luchetta T, Bernardin L, Garron D. Mood disturbance versus other symptoms of depression in multiple sclerosis. J. Int. Neuropsychol. Soc.1, 291–296 (1995).
  • Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory – Fast Screen in multiple sclerosis. Mult. Scler.9, 393–396 (2003).
  • Feinstein A, O’Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult. Scler.5, 323–326 (1999).
  • Benedict RH, Priore RL, Miller C, Munschauer F, Jacobs L. Personality disorder in multiple sclerosis correlates with cognitive impairment. J. Neuropsychiatry Clin. Neurosci.13, 70–76 (2001).
  • Benedict RHB, Hussein J, Englert J et al. Cortical atrophy and personality in multiple sclerosis. Neuropsychology22, 432–441 (2008).
  • Gioia MC, Cerasa A, Valentino P et al. Neurofunctional correlates of personality traits in relapsing–remitting multiple sclerosis: an fMRI study. Brain Cogn.71, 320–327 (2010).
  • Phennings LE, Polman CH, van der Ploeg HM. Quality of life in multiple sclerosis. MS Manag.2, 26–30 (1995).
  • Meyers AR, Gage H, Hendricks A. Health-related quality of life in neurology. Arch. Neurol.57, 1224–1227 (2000).
  • Kornblith AB, LaRocca NG, Baum HM. Employment in individuals with multiple sclerosis. Int. J. Rehabil. Res.9, 155–165 (1986).
  • Hakim E, Bakheit AM, Bryant TN et al. The social impact of multiple sclerosis – a study of 305 patients and their relatives. Disabil. Rehabil.22(6), 288–293 (2000).
  • Patten S, Svenson, LW, Metz LM. Descriptive epidemiology of affective disorders in multiple sclerosis. CNS Spectr.10(5), 365–371 (2005).
  • Ferrier S, Dunlop N, Blanchard C. The role of outcome expectations and self-efficacy in explaining physical activity behaviors of individuals with multiple sclerosis. Behav. Med.36, 7–11 (2010).
  • Pfennings L, Cohen L, Ader H et al. Exploring differences between subgroups of multiple sclerosis patients in health-related quality of life. J. Neurol.246(7), 587–591 (1999).
  • Schwartz C, Frohner R. Contribution of demographic, medical, and social support variables in predicting the mental health dimension of quality of life among people with multiple sclerosis. Health Soc. Work30(3), 203–212 (2005).
  • Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue, and disability. Mult. Scler.7, 340–344 (2001).
  • Benito-Leon J, Morales JM, Rivera-Navarro J. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients. Eur. J. Neurology9, 497–502 (2002).
  • Glanz B, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. J. Neurol. Sci.290, 75–79 (2010).
  • Cutajar R, Ferriani E, Scandellari C et al. Cognitive function and quality of life in multiple sclerosis patients. J. Neurovirol.6(Suppl. 2), 186–190 (2000).
  • D’Alisa S, Miscio G, Baudo S, Simone A, Tesio L, Mauro A. Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study. Disabil. Rehabil.28(5), 307–314 (2006).
  • Lobentanz I, Asenbaum, S, Vass, K et al. Factors influencing quality of life in multiple sclerosis: disability, depressive mood, fatigue and sleep quality. Acta Neurol. Scand.110, 6–13 (2004).
  • Benito-Leon J, Morales JM, Rivera-Navarro J, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disabil. Rehabil.25(23), 1291–1303 (2003).
  • Janardhan V, Bakshi, R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J. Neurol. Sci.205, 51–58 (2002).
  • De Stefano N, Bartolozzi ML, Nacmias B et al. Influence of apolipoprotein E ε4 genotype on brain tissue integrity in relapsing–remitting multiple sclerosis. Arch. Neurol.61, 536–540 (2004).
  • Cerasa A, Tongiorgi E, Fera F et al. The effects of BDNF Val 66 Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behav. Brain Res.207, 377–386 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.